IPO registrations (S-1, F-1) · Registrants
BioLife4D Corp
- SEC CIK
- 1714919 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2022-06-03, last 2023-06-13; 1 initial registration, 15 amendments
- Outcome
- No final prospectus, effectiveness notice or withdrawal within two years of the registration
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 318 HALF DAY ROAD, SUITE 201, Buffalo Grove, IL 60089
- EIN
- 81-4586116
- EDGAR entity type
- other
Offering terms
- Proposed price range
- $5.20–$7.20 per share (S-1/A filed 2023-06-13)
- Shares offered
- 241,936
- Listing
- Nasdaq under the symbol SAVU
- Lead underwriters
- Capital Corp
- Syndicate
- of Contents; Aegis Capital
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: BIOLIFE4D CORPORATION Fuzzy (name and state)
- Form D issuer: BioLife4D Corp EXACT (CIK (EXACT))
Filings 16
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2022-06-03 | S-1 | S-1 (registration) | BioLife4D Corp | 0001493152-22-015811 ↗ |
| 2022-06-17 | S-1/A | S-1/A (amendment) | BioLife4D Corp | 0001493152-22-017179 ↗ |
| 2022-07-21 | S-1/A | S-1/A (amendment) | BioLife4D Corp | 0001493152-22-020059 ↗ |
| 2022-09-08 | S-1/A | S-1/A (amendment) | BioLife4D Corp | 0001493152-22-025292 ↗ |
| 2022-09-21 | S-1/A | S-1/A (amendment) | BioLife4D Corp | 0001493152-22-026484 ↗ |
| 2022-10-04 | S-1/A | S-1/A (amendment) | BioLife4D Corp | 0001493152-22-027539 ↗ |
| 2022-11-02 | S-1/A | S-1/A (amendment) | BioLife4D Corp | 0001493152-22-030165 ↗ |
| 2022-11-15 | S-1/A | S-1/A (amendment) | BioLife4D Corp | 0001493152-22-032480 ↗ |
| 2022-11-23 | S-1/A | S-1/A (amendment) | BioLife4D Corp | 0001493152-22-033623 ↗ |
| 2022-12-19 | S-1/A | S-1/A (amendment) | BioLife4D Corp | 0001493152-22-035906 ↗ |
| 2023-01-04 | S-1/A | S-1/A (amendment) | BioLife4D Corp | 0001493152-23-000291 ↗ |
| 2023-04-20 | S-1/A | S-1/A (amendment) | BioLife4D Corp | 0001493152-23-013007 ↗ |
| 2023-05-01 | S-1/A | S-1/A (amendment) | BioLife4D Corp | 0001493152-23-015019 ↗ |
| 2023-05-08 | S-1/A | S-1/A (amendment) | BioLife4D Corp | 0001493152-23-015827 ↗ |
| 2023-05-12 | S-1/A | S-1/A (amendment) | BioLife4D Corp | 0001493152-23-016616 ↗ |
| 2023-06-13 | S-1/A | S-1/A (amendment) | BioLife4D Corp | 0001493152-23-021066 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-13 | S-1/A | registration statement | $5.20–$7.20 | $6.20 | 241,936 | $1,500,003 | Nasdaq SAVU | 3 | primary document; range, price sentence, shares headline, proceeds computed, cover names 3 | document ↗ |
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2019-02-25 | BioLife4D Corp | Biotechnology | $3,000,000 | $600,000 | 5 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | BIOLIFE4D CORPORATION | IL | State business registries | name and state |
| Form D issuer | BioLife4D Corp | IL | Form D private offerings | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), IL first:
- AveXis, Inc. IL
- Viskase Holdings, Inc. IL
- APPLIED NEUROSOLUTIONS INC IL
- NEOPHARM INC IL
- BioNTech SE 2M
- Immatics N.V. 2M
- CHEMOKINE THERAPEUTICS CORP A1
- Fusion Pharmaceuticals Inc. A6
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. AZ
- GENETIC TECHNOLOGIES LTD C3
In other datasets, the same topic (Health) in IL:
- Nonprofit: 5 LOAVES 2 FISHES FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health